Cloxib may be available in the countries listed below.
Ingredient matches for Cloxib
Celecoxib is reported as an ingredient of Cloxib in the following countries:
- Argentina
International Drug Name Search
Cloxib may be available in the countries listed below.
Celecoxib is reported as an ingredient of Cloxib in the following countries:
International Drug Name Search
Afumix may be available in the countries listed below.
Fluconazole is reported as an ingredient of Afumix in the following countries:
Tinidazole is reported as an ingredient of Afumix in the following countries:
International Drug Name Search
Prostacure may be available in the countries listed below.
Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Prostacure in the following countries:
International Drug Name Search
Ecazide may be available in the countries listed below.
Captopril is reported as an ingredient of Ecazide in the following countries:
Hydrochlorothiazide is reported as an ingredient of Ecazide in the following countries:
International Drug Name Search
Indomet Heumann may be available in the countries listed below.
Indometacin is reported as an ingredient of Indomet Heumann in the following countries:
International Drug Name Search
Acemav may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Acepromazine maleate (a derivative of Acepromazine) is reported as an ingredient of Acemav in the following countries:
International Drug Name Search
Carbesia may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Imidocarb dipropionate (a derivative of Imidocarb) is reported as an ingredient of Carbesia in the following countries:
International Drug Name Search
Inflabion may be available in the countries listed below.
Diacerein is reported as an ingredient of Inflabion in the following countries:
International Drug Name Search
Cardopril may be available in the countries listed below.
Captopril is reported as an ingredient of Cardopril in the following countries:
International Drug Name Search
Immodium may be available in the countries listed below.
Loperamide is reported as an ingredient of Immodium in the following countries:
International Drug Name Search
Amefar may be available in the countries listed below.
Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Amefar in the following countries:
International Drug Name Search
Fucidin Intertulle may be available in the countries listed below.
Fusidic Acid is reported as an ingredient of Fucidin Intertulle in the following countries:
International Drug Name Search
Tycon may be available in the countries listed below.
Cefadroxil monohydrate (a derivative of Cefadroxil) is reported as an ingredient of Tycon in the following countries:
Tioconazole is reported as an ingredient of Tycon in the following countries:
International Drug Name Search
Axcel Fusidic may be available in the countries listed below.
Fusidic Acid is reported as an ingredient of Axcel Fusidic in the following countries:
International Drug Name Search
Asovorin may be available in the countries listed below.
Calcium Folinate is reported as an ingredient of Asovorin in the following countries:
International Drug Name Search
Bronchoparat may be available in the countries listed below.
Theophylline Sodium Glycinate is reported as an ingredient of Bronchoparat in the following countries:
International Drug Name Search
Amisulpride Winthrop may be available in the countries listed below.
Amisulpride is reported as an ingredient of Amisulpride Winthrop in the following countries:
International Drug Name Search
Rennie Gel Hydrotalcit may be available in the countries listed below.
Hydrotalcite is reported as an ingredient of Rennie Gel Hydrotalcit in the following countries:
International Drug Name Search
Alprazolam AbZ may be available in the countries listed below.
Alprazolam is reported as an ingredient of Alprazolam AbZ in the following countries:
International Drug Name Search
Aspirina Fabra may be available in the countries listed below.
Acetylsalicylic Acid is reported as an ingredient of Aspirina Fabra in the following countries:
International Drug Name Search
Apo-Bisoprolol may be available in the countries listed below.
Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Apo-Bisoprolol in the following countries:
International Drug Name Search
Carboplatino Servycal may be available in the countries listed below.
Carboplatin is reported as an ingredient of Carboplatino Servycal in the following countries:
International Drug Name Search
Celenta may be available in the countries listed below.
Celecoxib is reported as an ingredient of Celenta in the following countries:
International Drug Name Search
Isozol may be available in the countries listed below.
Thiamylal sodium (a derivative of Thiamylal) is reported as an ingredient of Isozol in the following countries:
International Drug Name Search
Meverine may be available in the countries listed below.
Mebeverine hydrochloride (a derivative of Mebeverine) is reported as an ingredient of Meverine in the following countries:
International Drug Name Search
Glaucoval may be available in the countries listed below.
Brimonidine tartrate (a derivative of Brimonidine) is reported as an ingredient of Glaucoval in the following countries:
International Drug Name Search
Chloordiazepoxide CF may be available in the countries listed below.
Chlordiazepoxide is reported as an ingredient of Chloordiazepoxide CF in the following countries:
International Drug Name Search
Eficef may be available in the countries listed below.
Cefixime is reported as an ingredient of Eficef in the following countries:
International Drug Name Search
Prostalin may be available in the countries listed below.
Beraprost sodium (a derivative of Beraprost) is reported as an ingredient of Prostalin in the following countries:
International Drug Name Search
Cipflox may be available in the countries listed below.
Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Cipflox in the following countries:
International Drug Name Search
Betapred may be available in the countries listed below.
Betamethasone 21-(disodium phosphate) (a derivative of Betamethasone) is reported as an ingredient of Betapred in the following countries:
International Drug Name Search
Aplatic may be available in the countries listed below.
Ticlopidine hydrochloride (a derivative of Ticlopidine) is reported as an ingredient of Aplatic in the following countries:
International Drug Name Search
Ibuprofène Sandoz may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Ibuprofène Sandoz in the following countries:
International Drug Name Search
Xolvax may be available in the countries listed below.
Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Xolvax in the following countries:
International Drug Name Search
Lévodropropizine may be available in the countries listed below.
Lévodropropizine (DCF) is also known as Levodropropizine (Rec.INN)
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Ambroxol axcount may be available in the countries listed below.
Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Ambroxol axcount in the following countries:
International Drug Name Search
Apo-Methylphenidate may be available in the countries listed below.
Methylphenidate hydrochloride (a derivative of Methylphenidate) is reported as an ingredient of Apo-Methylphenidate in the following countries:
International Drug Name Search
Alendron-70 may be available in the countries listed below.
Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Alendron-70 in the following countries:
International Drug Name Search
Leptal may be available in the countries listed below.
Oxcarbazepine is reported as an ingredient of Leptal in the following countries:
International Drug Name Search
Moz-Bite may be available in the countries listed below.
Crotamiton is reported as an ingredient of Moz-Bite in the following countries:
International Drug Name Search
Bicardial B may be available in the countries listed below.
Sodium Bicarbonate is reported as an ingredient of Bicardial B in the following countries:
International Drug Name Search
In the US, Malarone (atovaquone/proguanil systemic) is a member of the drug class antimalarial combinations and is used to treat Malaria and Malaria Prevention.
US matches:
UK matches:
Atovaquone is reported as an ingredient of Malarone in the following countries:
Proguanil is reported as an ingredient of Malarone in the following countries:
Proguanil hydrochloride (a derivative of Proguanil) is reported as an ingredient of Malarone in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Amfazol may be available in the countries listed below.
Ketoconazole is reported as an ingredient of Amfazol in the following countries:
International Drug Name Search
Cebran may be available in the countries listed below.
Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Cebran in the following countries:
International Drug Name Search
REVAXIS
Suspension for injection in pre-filled syringe
Diphtheria, tetanus and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)
Each dose (0.5 ml) contains:
Active ingredients:
Purified diphtheria toxoid ............ not less than 2 IU* (5 Lf)
Purified tetanus toxoid ............ not less than 20 IU* (10 Lf)
Inactivated poliomyelitis virus type 1**....................... 40 D antigen units***
Inactivated poliomyelitis virus type 2**………………..……………... 8 D antigen units***
Inactivated poliomyelitis virus type 3**…………………………….…32 D antigen units***
aluminium hydroxide as adsorbant…………………………………… 0.35 mg (as aluminium)
For a full list of excipients, see section 6.1
* As lower confidence limit (p = 0.95) of activity measured according to the assay described in the European Pharmacopoeia.
** Produced in Vero cells.
*** Or equivalent antigenic quantity determined by a suitable immunochemical method
Suspension for injection in pre-filled syringe.
The vaccine has a cloudy white appearance.
REVAXIS is indicated for active immunisation against diphtheria, tetanus and poliomyelitis in children from six years of age, adolescents and adults as a booster following primary vaccination.
REVAXIS is not intended for primary immunisation.
Posology
The dose for children from the age of six years, adolescents and adults is 0.5 ml.
REVAXIS should be administered in accordance with official recommendations and/or local practice regarding the use of vaccines that provide reduced dose diphtheria toxoid plus tetanus toxoid in combination with inactivated poliomyelitis viruses.
REVAXIS may be used as a booster following primary immunisation with inactivated or oral poliomyelitis vaccines (IPV or OPV). There are no clinical data available regarding the use of REVAXIS in individuals with an incomplete, or no, history of a primary series of diphtheria and tetanus toxoids or of vaccinations against poliomyelitis.
Although REVAXIS has not been studied in subjects with tetanus-prone injuries, studies have shown that it induces similar tetanus antitoxin titres to Td vaccine. REVAXIS may therefore be used in subjects with tetanus-prone injuries if concomitant vaccination against diphtheria and poliomyelitis is desirable.
Method of Administration
REVAXIS is for intramuscular injection only. The recommended injection site is the deltoid region.
REVAXIS must not be administered by intradermal or intravascular routes.
Under certain conditions (e.g. bleeding disorders) REVAXIS may be administered as a deep subcutaneous injection.
For further instructions for use see section 6.6.
Hypersensitivity to diphtheria, tetanus or poliomyelitis vaccines or to any other ingredient of the vaccine.
Hypersensitivity to neomycin, streptomycin or polymyxin B. These are used during production and traces may remain in the vaccine.
Acute severe febrile illness. The presence of a minor infection is not a contraindication.
Neurological complications following an earlier immunisation against diphtheria and/or tetanus.
As for all vaccines, appropriate medical treatment should be readily available for immediate use in case of an anaphylactic reaction following vaccination.
REVAXIS should under no circumstances be administered intravascularly. The intradermal route must not be used either.
The immunogenicity of the vaccine could be reduced in immunosuppressed subjects. Where possible, vaccination should be postponed until immune function has recovered. However, vaccination of subjects with chronic immunodeficiency, such as AIDS, is recommended even if the antibody response might be limited.
REVAXIS must be administered with caution to subjects with thrombocytopenia or a bleeding disorder since bleeding may occur following an intramuscular administration to such subjects.
In order to minimise the risk of adverse events, REVAXIS should not be administered to subjects who completed a primary vaccination course or received a booster of a vaccine containing diphtheria or tetanus toxoids within the previous five years.
If Guillain-Barré syndrome or brachial neuritis has occurred following receipt of prior vaccine containing tetanus toxoid, the decision to give any vaccine containing tetanus toxoid should be based on careful consideration of the potential benefits and possible risks.
REVAXIS may be administered at the same time as other vaccines or immunoglobulins provided that the injections are made at separate site.
Subjects who are taking immunosuppressive agents may not respond to REVAXIS (see section 4.4).
The effect of REVAXIS on embryo-foetal development has not been assessed in animals. No teratogenic effect of vaccines containing diphtheria or tetanus toxoids, or inactivated poliovirus has been observed following use in pregnant women. However, this vaccine should not be administered to pregnant women unless it is considered urgent to boost immunity.
REVAXIS may be administered to breastfeeding women.
Vertigo has been reported following vaccination.
The adverse events are ranked under headings of frequency using the following convention:
|
|
|
|
|
|
|
|
|
|
Data from pre-approval clinical studies
In clinical studies, the most common events occurring after vaccine administration were local injection site reactions (pain, erythema, induration and oedema) reported by 65 to 80% of subjects in each trial. These usually had their onset within the 48 hours following vaccination and persisted for 1 to 2 days. These reactions are sometimes accompanied by injection site nodules.
| ||
|
| |
| ||
| ||
|
| |
| ||
| ||
|
| |
| ||
| ||
|
| |
| ||
| ||
|
| |
|
| |
| ||
| ||
|
| |
|
| |
|
| |
Data from post-marketing surveillance:
Based on spontaneous reporting, the following additional adverse events have been reported during the commercial use of REVAXIS.
These events have been very rarely reported, however exact incidence rates cannot precisely be calculated.
Nervous system disorders
Convulsions, Guillain Barre syndrome, brachial neuritis, transient paresthesia and hypoesthesia of the vaccinated limb, vasovagal syncope
Gastrointestinal disorders
Abdominal pain, diarrhoea
Skin and subcutaneous tissue disorders
allergic-type reactions such as urticaria, various types of rash, and face oedema
Musculoskeletal and connective tissue disorders
Pain in vaccinated limb
General disorders and administration site conditions
Large injection site reaction (>50 mm), including extensive limb swelling from the injection site beyond one or both joints have been reported. These reactions start within 24-72 hours after vaccination, may be associated with erythema, warmth, tenderness or pain at the injection site and resolve spontaneously within 3-5 days.
Pallor, asthenia, usually occurring and resolving within a few days, chills, influenza-like symptoms, mostly the same day as the vaccination
Immune system disorder:
systemic allergic / anaphylactic reactions including shock
Not documented.
Pharmacotherapeutic group: Vaccine against diphtheria, tetanus and poliomyelitis
ATC code: J07CA01
During clinical studies, the immunogenicity of REVAXIS was evaluated in 661 healthy subjects aged six to 78 years. In subjects vaccinated within ten years of a previous dose of diphtheria/tetanus/poliomyelitis vaccine, more than 99% achieved protective antibody levels for diphtheria, tetanus and poliomyelitis (types 1, 2 and 3) one month after receiving REVAXIS .
In a clinical study carried out in 113 healthy subjects aged 40 to 78 years who received their last vaccination against diphtheria, tetanus and poliomyelitis more than ten years ago, REVAXIS elicited a satisfactory booster response.
Antibody persistence over a two-year period was assessed in 113 healthy adults. Two years after receiving a dose of REVAXIS the proportions of subjects with protective titres against diphtheria, tetanus and poliomyelitis (types 1, 2 and 3) were 100%, 94.7% and 100% respectively. In a clinical study in 151 healthy children aged six to nine years, antibody titres at one month after a dose of REVAXIS were approximately three-fold higher than those seen in the healthy adults at two years post-dose. Therefore, it may be anticipated that antibody levels in children would be at least as good as those observed in adults at two years post-dose.
Evaluation of pharmacokinetic properties is not required for vaccines.
Preclinical data reveal no special hazard for humans based on conventional studies of safety, specific toxicity and compatibility of ingredients.
Phenoxyethanol
Formaldehyde
Medium 199*
Water for injections
* Medium 199 is a complex medium of amino acids, mineral salts, vitamins, polysorbate 80 and other substances diluted in water for injections.
In the absence of compatibility studies, the vaccine must not be mixed with other medicinal products.
3 years
Store in a refrigerator (2°C to 8°C).
Do not freeze. Discard the vaccine if it has been frozen.
0.5 ml of suspension in pre-filled syringe (0.5 ml, type I glass) with a plunger-stopper (chlorobromobutyl elastomer) and attached needle and needle-guard (natural rubber or polyisoprene elastomer).
0.5 ml of suspension in pre-filled syringe (0.5 ml, type I glass) with a plunger-stopper (chlorobromobutyl elastomer) and tip-cap (chlorobromobutyl elastomer), without needle.
Packs of 1, 10 and 20 syringes.
0.5 ml of suspension in pre-filled syringe (0.5 ml, type I glass) with a plunger-stopper (chlorobromobutyl elastomer) and tip-cap (chlorobromobutyl elastomer), with 1 or 2 separate needles (for each syringe).
Packs of 1 and 10 syringes.
Not all pack sizes and presentations may be marketed.
For needle free syringes, the needle should be pushed firmly on to the end of the pre-filled syringe and rotated through 90 degrees.
The vaccine's normal appearance is a cloudy white suspension that may sediment during storage. Shake the pre-filled syringe well to distribute uniformly the suspension before administering the vaccine.
Parenteral biological products should be inspected visually for extraneous particulate matter and/or discolouration prior to administration. In the event of either being observed, discard the vaccine.
Any unused product or waste material should be disposed of in accordance with local requirements.
Sanofi Pasteur MSD Limited
Mallards Reach
Bridge Avenue
Maidenhead
Berkshire
SL6 1QP
PL06745/0123
3rd June 2003/4th April 2008
April 2008
Migraspirina may be available in the countries listed below.
Acetylsalicylic Acid is reported as an ingredient of Migraspirina in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Phenylbutazone is reported as an ingredient of Bizolin in the following countries:
International Drug Name Search
Carepen may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Carepen in the following countries:
International Drug Name Search
Inongan may be available in the countries listed below.
Camphor is reported as an ingredient of Inongan in the following countries:
Methyl Salicylate is reported as an ingredient of Inongan in the following countries:
International Drug Name Search
Regasec may be available in the countries listed below.
Omeprazole is reported as an ingredient of Regasec in the following countries:
International Drug Name Search
Lidocain Human may be available in the countries listed below.
Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Lidocain Human in the following countries:
International Drug Name Search
Amlodin may be available in the countries listed below.
Amlodipine is reported as an ingredient of Amlodin in the following countries:
Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Amlodin in the following countries:
International Drug Name Search
B02AA03
0000056-91-7
C8-H9-N-O2
151
Hemostatic agent
Benzoic acid, 4-(aminomethyl)-
International Drug Name Search
Glossary
| IS | Inofficial Synonym |
Cortal may be available in the countries listed below.
Acetylsalicylic Acid is reported as an ingredient of Cortal in the following countries:
International Drug Name Search
Rechol may be available in the countries listed below.
Simvastatin is reported as an ingredient of Rechol in the following countries:
International Drug Name Search
Mecalmin may be available in the countries listed below.
Difenidol hydrochloride (a derivative of Difenidol) is reported as an ingredient of Mecalmin in the following countries:
International Drug Name Search
Menthol may be available in the countries listed below.
Menthol (DCF) is also known as Levomenthol (Rec.INN)
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
In the US, PREZISTA (darunavir systemic) is a member of the drug class protease inhibitors and is used to treat HIV Infection.
US matches:
UK matches:
Darunavir is reported as an ingredient of PREZISTA in the following countries:
Darunavir ethanolate (a derivative of Darunavir) is reported as an ingredient of PREZISTA in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
FNI 2b may be available in the countries listed below.
Interferon alfa Interferon alfa-2b (Arg-23; His-34) (a derivative of Interferon alfa) is reported as an ingredient of FNI 2b in the following countries:
International Drug Name Search
Paramolan may be available in the countries listed below.
Paracetamol is reported as an ingredient of Paramolan in the following countries:
International Drug Name Search
Blok-L may be available in the countries listed below.
Vecuronium Bromide is reported as an ingredient of Blok-L in the following countries:
International Drug Name Search
Jzoloft may be available in the countries listed below.
Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Jzoloft in the following countries:
International Drug Name Search
Isotears may be available in the countries listed below.
Dextran average molecular weight about 70000 (a derivative of Dextran) is reported as an ingredient of Isotears in the following countries:
Hypromellose is reported as an ingredient of Isotears in the following countries:
International Drug Name Search
GenRX Amoxycillin and Clavulanic Acid may be available in the countries listed below.
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of GenRX Amoxycillin and Clavulanic Acid in the following countries:
Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of GenRX Amoxycillin and Clavulanic Acid in the following countries:
International Drug Name Search
Lopisol may be available in the countries listed below.
Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Lopisol in the following countries:
International Drug Name Search
Isoriac may be available in the countries listed below.
Isotretinoin is reported as an ingredient of Isoriac in the following countries:
International Drug Name Search
Basofortina may be available in the countries listed below.
Methylergometrine maleate (a derivative of Methylergometrine) is reported as an ingredient of Basofortina in the following countries:
International Drug Name Search
Calol may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Calcium Chloride is reported as an ingredient of Calol in the following countries:
Magnesium Chloride is reported as an ingredient of Calol in the following countries:
International Drug Name Search
Celipress may be available in the countries listed below.
Celiprolol hydrochloride (a derivative of Celiprolol) is reported as an ingredient of Celipress in the following countries:
International Drug Name Search
Klacid One may be available in the countries listed below.
Clarithromycin is reported as an ingredient of Klacid One in the following countries:
International Drug Name Search
ratio-Gabapentin may be available in the countries listed below.
Gabapentin is reported as an ingredient of ratio-Gabapentin in the following countries:
International Drug Name Search
Gatsina may be available in the countries listed below.
Gatifloxacin is reported as an ingredient of Gatsina in the following countries:
International Drug Name Search
Chevi-Trim may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Sulfamethoxazole is reported as an ingredient of Chevi-Trim in the following countries:
Trimethoprim is reported as an ingredient of Chevi-Trim in the following countries:
International Drug Name Search
In the US, Mineral Oil (mineral oil systemic) is a member of the drug class laxatives.
US matches:
Mineral Oil (USAN) is also known as Paraffin liquid (Ph. Eur.)
International Drug Name Search
Glossary
| Ph. Eur. | European Pharmacopoeia |
| USAN | United States Adopted Name |
In some countries, this medicine may only be approved for veterinary use.
In the US, Travatan (travoprost ophthalmic) is a member of the drug class ophthalmic glaucoma agents and is used to treat Glaucoma - Open Angle and Intraocular Hypertension.
US matches:
UK matches:
Travoprost is reported as an ingredient of Travatan in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Iodio Zeta may be available in the countries listed below.
Iodine is reported as an ingredient of Iodio Zeta in the following countries:
Potassium Iodide is reported as an ingredient of Iodio Zeta in the following countries:
International Drug Name Search
Clamentin may be available in the countries listed below.
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Clamentin in the following countries:
Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Clamentin in the following countries:
International Drug Name Search
Galastat may be available in the countries listed below.
Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Galastat in the following countries:
International Drug Name Search
Paranox may be available in the countries listed below.
Paracetamol is reported as an ingredient of Paranox in the following countries:
International Drug Name Search
Cabergolin Stada may be available in the countries listed below.
Cabergoline is reported as an ingredient of Cabergolin Stada in the following countries:
International Drug Name Search
GenRX Tamoxifen may be available in the countries listed below.
Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of GenRX Tamoxifen in the following countries:
International Drug Name Search
Cardimax may be available in the countries listed below.
Trimetazidine dihydrochloride (a derivative of Trimetazidine) is reported as an ingredient of Cardimax in the following countries:
International Drug Name Search
Loprolol may be available in the countries listed below.
Metoprolol tartrate (a derivative of Metoprolol) is reported as an ingredient of Loprolol in the following countries:
International Drug Name Search
Bioflevin may be available in the countries listed below.
Diosmin is reported as an ingredient of Bioflevin in the following countries:
Hesperidin is reported as an ingredient of Bioflevin in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Benzylpenicillin potassium (a derivative of Benzylpenicillin) is reported as an ingredient of Penicillin G in the following countries:
Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Penicillin G in the following countries:
Benzylpenicillin sodium (a derivative of Benzylpenicillin) is reported as an ingredient of Penicillin G in the following countries:
International Drug Name Search
Insulin soluble may be available in the countries listed below.
Insulin Injection, Soluble porcine or bovine (a derivative of Insulin Injection, Soluble) is reported as an ingredient of Insulin soluble in the following countries:
International Drug Name Search
Enalapril Bluepharma may be available in the countries listed below.
Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril Bluepharma in the following countries:
International Drug Name Search
Tensaar may be available in the countries listed below.
Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Tensaar in the following countries:
International Drug Name Search
Pancuronio Gray may be available in the countries listed below.
Pancuronium Bromide is reported as an ingredient of Pancuronio Gray in the following countries:
International Drug Name Search
Tafil may be available in the countries listed below.
Alprazolam is reported as an ingredient of Tafil in the following countries:
International Drug Name Search
Rarpefluc may be available in the countries listed below.
Fluconazole is reported as an ingredient of Rarpefluc in the following countries:
International Drug Name Search
Lonarid may be available in the countries listed below.
Caffeine is reported as an ingredient of Lonarid in the following countries:
Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Lonarid in the following countries:
Paracetamol is reported as an ingredient of Lonarid in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Rec.INN
A11HA31,D03AX04
0000137-08-6
C18-H32-Ca-N2-O10
476
Wound healing agent
Vitamin
Calcium bis[(R)-N-(2,4-dihydroxy-3,3-dimethylbutyryl)-ß-alaninate] (WHO)
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| WHO | World Health Organization |
TopiLEK may be available in the countries listed below.
Topiramate is reported as an ingredient of TopiLEK in the following countries:
International Drug Name Search
Gynosant may be available in the countries listed below.
Fluconazole is reported as an ingredient of Gynosant in the following countries:
International Drug Name Search
Klarfast may be available in the countries listed below.
Loratadine is reported as an ingredient of Klarfast in the following countries:
International Drug Name Search
Phendimetrazine tartrate (a derivative of Phendimetrazine) is reported as an ingredient of X-Trozine in the following countries:
International Drug Name Search
Médrogestone may be available in the countries listed below.
Médrogestone (DCF) is also known as Medrogestone (Rec.INN)
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Cellmustin may be available in the countries listed below.
Estramustine 17ß-(disodium phosphate) (a derivative of Estramustine) is reported as an ingredient of Cellmustin in the following countries:
International Drug Name Search
Tiroxmen may be available in the countries listed below.
Levothyroxine is reported as an ingredient of Tiroxmen in the following countries:
International Drug Name Search
Tramadol Streuli may be available in the countries listed below.
Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Tramadol Streuli in the following countries:
International Drug Name Search